Skip to content
Toggle main navigation
About
About TEPHINET
About TEPHIConnect
Terms of Use and Privacy
How to Join
Why Join?
News
Events
Groups
Journals
BMC Medicine
BMC Medical Research Methodology
Clinical Epidemiology and Global Health
Emerging Microbes & Infections
Frontiers in Epidemiology
Global Health Journal
International Journal of Epidemiology
Online Library Journal
PLoS One
Science Direct Journal (Global Health)
Science Direct Journal (Clinical Epidemiology and Global Health)
More
Open dropdown to see remaining menu items
Log in
Request to join
AFENET COVID-19 at a Glance # 135
Published on March 29, 2021
AFENET COVID-19 at a Glance
Issue # 135
Other news
EARLY RELEASE: Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, De...
March 29, 2021
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions.
AFENET COVID-19 at a Glance # 136
March 31, 2021
AFENET COVID-19 at a Glance Issue #136 is now available